News und Analysen
indie Semiconductor Q2 Earnings Call Highlights
Key Points
- Interested in indie Semiconductor, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose 24% year over year to $64 million, exceeding the midpoint of guidance by $2
ICU Medical Q2 Earnings Call Highlights
Key Points
- Interested in ICU Medical, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Revenue reached $548 million, with organic growth of 6%; adjusted EBITDA
Hyperfine Q2 Earnings Call Highlights
Key Points
- Interested in Hyperfine, Inc.? Here are five stocks we like better.
- Revenue and system sales accelerated: Second-quarter revenue rose 45% year over year to $3.9 million, with 12
Funko Q2 Earnings Call Highlights
Key Points
- Interested in Funko, Inc.? Here are five stocks we like better.
- Funko’s second-quarter sales rose 7% year over year, with particularly strong growth in Europe and core collectibles
Cytokinetics Q2 Earnings Call Highlights
Key Points
- Interested in Cytokinetics, Incorporated? Here are five stocks we like better.
- MYQORZO’s U.S. launch is gaining traction: The drug reached 1,500 dispensed patients and more than 700
CytomX Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in CytomX Therapeutics, Inc.? Here are five stocks we like better.
- Varseta-M remains CytomX’s primary focus: The Phase I monotherapy study has enrolled 113 patients, with
Corvus Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Corvus Pharmaceuticals, Inc.? Here are five stocks we like better.
- Corvus reported a wider Q2 loss as research and development spending rose to $16 million for
Coincheck Group Q1 Earnings Call Highlights
Key Points
- Interested in Coincheck Group N.V.? Here are five stocks we like better.
- Revenue grew 36% year over year to JPY 114.3 billion, while adjusted revenue rose 19% to JPY 2.92 billion
Clarus Q2 Earnings Call Highlights
Key Points
- Interested in Clarus Corporation? Here are five stocks we like better.
- Second-quarter sales rose 1.6% to $56.2 million, led by 8.5% growth in the Outdoor segment, while Adventure
Century Aluminum Q2 Earnings Call Highlights
Key Points
- Interested in Century Aluminum Company? Here are five stocks we like better.
- Strong second-quarter results: Shipments rose 6% sequentially to about 131,000 tons, while sales increased
Consensus Cloud Solutions Q2 Earnings Call Highlights
Key Points
- Interested in Consensus Cloud Solutions, Inc.? Here are five stocks we like better.
- Q2 performance improved: Revenue rose 4.1% year over year to $91.4 million, while adjusted EPS
Atlanticus Q2 Earnings Call Highlights
Key Points
- Interested in Atlanticus Holdings Corporation? Here are five stocks we like better.
- Record second-quarter performance: Atlanticus increased net income attributable to common
Ardelyx Q2 Earnings Call Highlights
Key Points
- Interested in Ardelyx, Inc.? Here are five stocks we like better.
- Second-quarter product revenue reached a record $118 million, up 31% year over year, but Ardelyx lowered its 2026
Apyx Medical Q2 Earnings Call Highlights
Key Points
- Interested in Apyx Medical Corporation? Here are five stocks we like better.
- Revenue rose 22% to $13.9 million in the second quarter, driven by a 28% increase in surgical aesthetics
Applied Optoelectronics Q2 Earnings Call Highlights
Key Points
- Interested in Applied Optoelectronics, Inc.? Here are five stocks we like better.
- Record growth and profitability: Second-quarter revenue reached $191.9 million, up 86% year over
MACOM Technology Solutions Q3 Earnings Call Highlights
Key Points
- Interested in MACOM Technology Solutions Holdings, Inc.? Here are five stocks we like better.
- Record third-quarter performance: MACOM’s revenue rose 35.8% year over year to $342.2
MKS Q2 Earnings Call Highlights
Key Points
- Interested in MKS Inc.? Here are five stocks we like better.
- MKS reported strong second-quarter results, with revenue of $1.25 billion, up 16% sequentially and 28% year over year
Ligand Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Ligand Pharmaceuticals Incorporated? Here are five stocks we like better.
- Q2 results strengthened: Revenue rose 34% year over year to $64 million, royalty revenue
Deutz AG Aktie: 1,6-Milliarden-Übernahme von FFG vereinbart
Der Kölner Motorenbauer Deutz hat am Donnerstag seine Halbjahreszahlen vorgelegt – und gleich eine…
Der Beitrag Deutz AG Aktie: 1,6-Milliarden-Übernahme von FFG vereinbart erschien zuerst auf kapita
Insmed Q2 Earnings Call Highlights
Key Points
- Interested in Insmed, Inc.? Here are five stocks we like better.
- BRINSUPRI sales accelerated: Second-quarter revenue reached $309.2 million, up 49% sequentially, prompting Insmed to
Himax Technologies Q2 Earnings Call Highlights
Key Points
- Interested in Himax Technologies, Inc.? Here are five stocks we like better.
- Himax exceeded second-quarter guidance: Revenue rose 14.2% sequentially to $227.4 million, while gross
Renk Group Aktie: 1,05-Milliarden-Euro-Refinanzierung
Ein Auftragseingang von 1.195,1 Millionen Euro binnen sechs Monaten, ein Rekordquartal mit 612,8 Millionen…
Der Beitrag Renk Group Aktie: 1,05-Milliarden-Euro-Refinanzierung erschien zuerst auf kapi
Gladstone Commercial Q2 Earnings Call Highlights
Key Points
- Interested in Gladstone Commercial Corporation? Here are five stocks we like better.
- FFO increased: Second-quarter FFO and Core FFO each rose to $0.38 per share, up from $0.33 and
Gogo Q2 Earnings Call Highlights
Key Points
- Interested in Gogo Inc.? Here are five stocks we like better.
- Q2 revenue declined modestly to $222.8 million, while Gogo posted a $2 million net loss and adjusted EBITDA fell 13% year
GoodRx Q2 Earnings Call Highlights
Key Points
- Interested in GoodRx Holdings, Inc.? Here are five stocks we like better.
- GoodRx raised its full-year outlook after reporting Q2 revenue of $200.4 million and adjusted EBITDA of $63.7